Research Categories - Therapeutics
The range of studies that address therapeutics is expansive, encompassing biologic and cell-based therapies, small molecules, and diagnostics. Some examples include chimeric proteins for improving targeted therapy, stem cells for treating neurodegenerative diseases, radiolabeled prodrugs designed to offload cytotoxic activity only at the sites of tumors, and novel natural products having antibiotic properties.
Related Investigators
-
Jeremy Gunawardena, PhD
Experimental and theoretical analysis of signal transduction: EGF signaling, drug efficacy, phosphorylation states, microfluidics, formalized biology language
Investigate the dynamics of signal transduction, from a mechanistic and practical perspective. Describe at a fundamental level the input/output transformation that connects external signals to ...

-
Jose Halperin, MD
Targeting protein translation for anticancer therapies; CD59 and diabetes
Employ the preclinical resources of the Laboratory for Translational Research to develop new therapies and diagnostics in oncology and diabetes

-
Keith Mansfield, DVM
Infectious diseases and aging: simian AIDS; opportunistic infection; diet
Infectious diseases, aging, and dietary intervention.

-
Samara Reck-Peterson, PhD
Intracellular cargo movement: the role of molecular motors
Explore the role of dynein in molecular cargo transport

-
Peter Sorger, PhD
Systems biology applied to disease mechanisms and drug therapy
Translate activity-based proteomic data and computational modeling into practical applications for cancer therapies, inflammation studies, and personalized medicine.

-
Roger Spealman, PhD
CNS disorders: addiction; Parkinson’s disease
Studies on the mechanisms and efficacy of psychoactive drugs

-
Michael Starnbach, PhD
Bacterial infection and acquired immunity
T-cell response to bacterial infection, including sexually transmitted chlamydia disease

-
Fred Winston, PhD
Mechanisms of eukaryotic gene expression in yeast: transcriptional regulation; chromatin structure
Employs yeast as a model organism to study mechanisms of eukaryotic transcriptional regulation.

-
Priscilla Yang, PhD
Host response to viral infection and drug discovery: dengue virus, hepatitis B and C viruses
Investigate molecular mechanisms of dengue and hepatitis virus infection and replication; perform HTS for viral antagonists to identify host factors and pathways required for dengue virus infection ...

-
Bruce Yankner, MD, PhD
Molecular mechanisms of aging and aging-related neurodegenerative diseases
Explore aging at the molecular level, employing a systems biology approach

Sub-categories
-
Drug Development: Biologic Therapies
-
Drug Development: Cell-Based Therapies
-
Drug Development: Diagnostics
-
Drug Development: Non-Biologic Therapeutics and Small Molecules
- Adamantane»
- Anti-bacterial therapy»
- Anti-convulsant therapy»
- Anticancer therapy»
- Anticoagulant»
- Anticonvulsant therapy»
- Antifungal»
- Antioxidant»
- Antiviral small molecules»
- Antizyme»
- Anxiolytic»
- Benzodiazepine»
- Biologically-active small molecule»
- Cancer targets»
- Combination therapy»
- DNA damaging agents»
- Double mimetic»
- Druggable genome»
- EdU»
- HAART»
- Iressa»
- Medicinal chemistry»
- Muscle relaxant»
- Natural product»
- Natural products»
- Opioid»
- Peptide mimetic»
- Pharmacological agents»
- Prodrug»
- Recombinant toxins»
- Resveratol»
- Sedative»
- Small molecule chemistry»
- Small molecule inhibitors»
- Small molecule screens»
- Small molecule therapy»
- Small molecules»
- Soil microbe»
- Tarceva»